PROSPECTIVE COMPARATIVE STUDY OF TWO FIRST-LINE REGIMENS FOR HELICOBACTER PYLORI ERADICATION: 14-DAYS NON-BISMUTH QUADRUPLE OPTIMIZED CONCOMITANT THERAPY VERSUS 10-DAYS BISMUTH-CONTAINING QUADRUPLE THERAPY USING A THREE-IN-ONE CAPSULE. | Publicación